Navigation Links
MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results
Date:3/2/2009

mic drug exposure when compared to the currently marketed conventional nebulized budesonide.

MAP0004

  • Received a Special Protocol Assessment with the U.S. Food and Drug Administration, and initiated our first Phase 3 clinical trial of MAP0004, for the potential treatment of migraine. Completed patient enrollment in the efficacy portion of this trial. Data are expected in the first half of 2009.

Pipeline Development

  • Announced positive results from a Phase 2a clinical trial of MAP0005 for the potential treatment of asthma and chronic obstructive pulmonary disease (COPD).

Other

  • Appointed H. Ward Wolff, Executive Vice President and Chief Financial Officer of Sangamo BioSciences, Inc., and Scott R. Ward, Senior Vice President and President, Medtronic CardioVascular, to the board of directors.

Fourth Quarter and 2008 Year End Financial Results

Research and development expenses for the fourth quarter and year ended December 31, 2008 were $17.7 million and $59.3 million, respectively, compared to $13.0 million and $31.4 million, respectively, for the same periods in 2007. The increase in research and development expenses for the fourth quarter ended December 31, 2008 as compared to the same period in 2007 was primarily driven by an increase in clinical expenses to support Phase 3 clinical programs initiated in 2008 for our two lead product candidates, UDB and MAP0004, and an increase in personnel related expenses to support these clinical programs. The increase in research and development expenses for the year ended December 31, 2008 as compared to the year ended December 31, 2007 was primarily driven by an increase in clinical expenses to support Phase 3 clinical pro
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
2. Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
3. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
4. Alseres Pharmaceuticals, Inc. Announces $200,000 Financing
5. Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
6. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
7. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
8. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
9. Endo Pharmaceuticals Appoints William Montague to Board of Directors
10. Access Pharmaceuticals Closes Acquisition of MacroChem Corp.
11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... What does community do? , According to ... together to plant gardens, to teach young people, to ... critical issues. Community invites everyone to help improve lives ... Community Does" was commissioned by The Denver Foundation, the ... during the foundation’s Annual Celebration in May. At just ...
(Date:5/29/2015)... Fort Washington, PA (PRWEB) May 29, 2015 ... Doc ” quiz-based learning in 14 medical specialties, now ... quiz includes a wide spectrum of rheumatology disorders ranging ... , Alfred Saint Jacques, editorial director of MDLinx, and ... are excited about the impact it will have on ...
(Date:5/29/2015)... Ohio (PRWEB) May 29, 2015 John ... Experience to Cincinnati , The Department of Veterans Affairs ... A. Gennaro as the new director of the Cincinnati ... health care to more than 43,000 unique Veterans annually ... With over 2,000 staff, CVAMC is a two-division campus ...
(Date:5/29/2015)... CO (PRWEB) May 29, 2015 ... new addiction, substance abuse, and co-occurring mental health ... and ribbon cutting for the general public on ... 2nd. , The Recovery Village at Palmer Lake ... intensive outpatient programming, utilizing traditional and evidence-based therapies, ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Dot Hill can mark ... 91-year-old resident of Lake Prince Woods retirement community is ... in Virginia Beach, Virginia. , “It was great fun!”, she exclaimed. ... children didn’t want me to so they thought this would be ... stepped into a vertical wind tunnel,” she described. “I don’t ...
Breaking Medicine News(10 mins):Health News:What Community Does: A New Video from The Denver Foundation 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:VA Healthcare System of Ohio Network Announces New Medical Center Director 2Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Indoor Skydiving Brings Thrills to Seniors 2
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, Oct. ... outbreak first linked to tainted cantaloupes has risen to 25, ... 26 states, the U.S. Centers for Disease Control and Prevention ... the cantaloupes in question were recalled in mid-September, more cases ...
... as immunotherapies and targeted therapies that specifically target signaling ... in 20%-50% of cancer patients taking them, which can ... study published Oct. 18 in the Journal ... past two decades, novel antineoplastic agents have been introduced ...
... PROVIDENCE, R.I. [Brown University] A study published online Oct. ... provides some new but qualified support for the idea ... risk of developing deadly brain tumors. People with somewhat ... out the body,s immune response to allergens, were significantly less ...
... LeFevre, MD, Future of Family Medicine Professor and vice ... of Missouri, has been elected to the Institute of ... is considered one of the highest honors in the ... have demonstrated outstanding professional achievement and commitment to service. ...
... & White Healthcare in Temple is one of three sites ... doctoral psychology students that will help alleviate mental health workforce ... a five-year $638,853 grant from the Hogg Foundation for Mental ... will fund a new internship program that will enable students ...
... results from a large-scale Phase III trial of RTS,S*, published ... (NEJM), show the malaria vaccine candidate to provide young ... with an acceptable safety and tolerability profile. The results were ... & Melinda Gates Foundation in Seattle, Washington. Half the ...
Cached Medicine News:Health News:25 Deaths Now Blamed on Cantaloupe-Linked Listeria Outbreak 2Health News:Antineoplastic agents associated with thyroid dysfunction 2Health News:More evidence that allergies may help in fighting brain tumors 2Health News:Family and community medicine leader elected to Institute of Medicine 2Health News:Scott & White Healthcare is 1 of 3 in Texas to receive workforce development grants 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 2Health News:Malaria vaccine candidate, RTS,S reduces the risk of malaria by half in African children 3
(Date:5/28/2015)... , May 28, 2015 Zimmer Holdings, ... it has finalized agreements with buyers to divest in ... Unicompartmental High-Flex Knee System assets, Biomet Discovery® Elbow System ... are in furtherance of Zimmer,s pending acquisition of Biomet, ... Zimmer continues to work constructively with the Bureau of ...
(Date:5/28/2015)... NEW YORK , May 28, 2015 ... billions developing new drugs and tests, and ... for the instruments that can assist them. This ... research publisher. Kalorama Information said instruments such as ... can assist in the identification of drug ...
(Date:5/28/2015)... -- Maetrics ( http://maetrics.com ), a leading international consulting firm ... successful conference, "The cost of non-compliance -- How new regulation ... Zurich . Hosted by ... Switzerland -based team, experts provided insights on the ... an exclusive local audience. The event was held in ...
Breaking Medicine Technology:Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 2Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 3Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 4Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 5Zimmer Announces Agreements in Furtherance of Pending Biomet Merger 6Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
... , HARTFORD, Conn., Dec. 16 ... home health benefits management services, announced today that it ... Washington, DC-based health care accrediting organization that establishes quality ... that only appropriately trained, qualified clinical personnel conduct and ...
... , , ... it was awarded the 2009 Top Innovator Presentation Award,in ... on December 8th,at Dedham, MA. The award, which recognizes ... granted to Biovista who competed with,over 50 other privately ...
Cached Medicine Technology:CareCentrix Receives URAC Health Utilization Management Accreditation 2Biovista Inc. Named Top Innovator in Life Sciences 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: